Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
, reviewing laboratory results, managing treatment related complications, and collaborating with nursing and pharmacy staff to facilitate the safe delivery of chemotherapy, immunotherapy, anti-neoplastic
-
institute with translational research focusing on Alzheimer dementia and oncology. Learn more about how the University of Illinois College of Medicine Peoria is helping to transform healthcare here: https
-
, digestive, and germ cell cancers Research Line: IBIMA-B-05 TRANSLATIONAL RESEARCH IN CANCER IMMUNOTHERAPY AND EPIGENETICS Principal Investigator: ANTONIO RUEDA DOMINGUEZ Location: IBIMA Bionand Platform
-
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center) | Dallas, Texas | United States | 9 days ago
seeking a highly motivated and collaborative postdoctoral researcher to help develop the next generation of cancer immunotherapies. Our research integrates cancer immunology, T-cell and protein engineering
-
postdoctoral fellow will investigate the effects of novel immunotherapies in both in vitro and in vivo inflammatory models. They will contribute to antibody production and perform detailed structural and
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 10 hours ago
research. We foster programs in the areas of basic, translational, mechanistic and population research. Position Summary Our new Center for Generative Immunotherapy (CGI), a collaborative and
-
immunotherapy while mentoring graduate and undergraduate students. This is an excellent opportunity for early-career scientists looking to develop a strong publication record and build an independent research
-
, Nijmegen, the Netherlands Project background Cancer immunotherapy can direct a patient's own T cells to recognize tumor-specific neoantigens and destroy tumor cells, but its promise is held back by high cost
-
platforms, you will design and evaluate novel therapeutic strategies aimed at reprogramming the tumor microenvironment to potentiate chemo- and immunotherapy in vitro and in vivo. Key Responsibilities
-
immunotherapies for cancer patients with brain metastasis. Our group works at the interface between immunology and cancer biology combining the use of preclinical models of cancer and human samples with state